Raymond James Financial Services Advisors, Inc. Moderna, Inc. Call Options Transaction History

Raymond James Financial Services Advisors, Inc.

  • $69.1 Billion
  • Q2 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 11, 2022
SELL
$126.46 - $235.05 $1.25 Million - $2.33 Million
-9,900 Reduced 38.67%
15,700 $34,000
Q2 2021

Aug 11, 2021
BUY
$129.91 - $234.98 $3.33 Million - $6.02 Million
25,600 New
25,600 $1.19 Million

Others Institutions Holding MRNA

# of Institutions
1,113
Shares Held
241M
Call Options Held
9.26M
Put Options Held
12.1M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email